ID

25747

Description

Study ID: 101468/169 Clinical Study ID: 101468/169 Study Title:A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment with Ropinirole CR as Adjunctive Therapy in Patients with Parkinson's Disease who are not Optimally Controlled on L-dopa Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00381472 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Parkinson Disease This is the L-Dopa Medication form.

Mots-clés

Versions (2)
  1. 17/09/2017 17/09/2017 -
  2. 28/09/2017 28/09/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

17 septembre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

GSK Ropinirole in Patients Suffering from Parkinsons Disease L-Dopa Medication 101468/169 NCT00381472

Anglais

GSK Ropinirole in Patients Suffering from Parkinsons Disease L-Dopa Medication 101468/169 NCT00381472

1 Formulaires  
L-DOPA MEDICATION
Description

L-DOPA MEDICATION

Alias
UMLS CUI-1
C0023570
Was any L-Dopa taken by the subject during the study or within 30 days prior to the study? If Yes, record each instance below.
Description

Was any L-Dopa taken by the subject during the study or within 30 days prior to the study?

Type de données

boolean

Alias
UMLS CUI [1]
C0023570
Drug Name
Description

Drug Name

Type de données

text

Alias
UMLS CUI [1,1]
C0023570
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0023570
Unit Dose
Description

Unit Dose

Type de données

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0023570
UMLS CUI [1,3]
C0023570
UMLS CUI [1,4]
C0869039
Units
Description

Units

Type de données

text

Alias
UMLS CUI [1,1]
C1519795
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0023570
Frequency
Description

Frequency

Type de données

text

Alias
UMLS CUI [1,1]
C1519795
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0023570
Route
Description

Route

Type de données

text

Alias
UMLS CUI [1,1]
C0013153
UMLS CUI [1,2]
C0023570
UMLS CUI [1,3]
C0013227
Reason for Medication
Description

Reason for Medication

Type de données

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0023570
Start Date
Description

Start Date

Type de données

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0808070
UMLS CUI [1,3]
C0023570
Stop Date
Description

Stop Date

Type de données

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C0023570
Ongoing Medication?
Description

Ongoing Medication?

Type de données

boolean

Alias
UMLS CUI [1,1]
C0549178
UMLS CUI [1,2]
C0023570
Retour au début de la page

Similar models

GSK Ropinirole in Patients Suffering from Parkinsons Disease L-Dopa Medication 101468/169 NCT00381472

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
L-DOPA MEDICATION
C0023570 (UMLS CUI-1)
Was any L-Dopa taken by the subject during the study or within 30 days prior to the study?
Item
Was any L-Dopa taken by the subject during the study or within 30 days prior to the study? If Yes, record each instance below.
boolean
C0023570 (UMLS CUI [1])
Drug Name
Item
Drug Name
text
C0023570 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0023570 (UMLS CUI [1,3])
Unit Dose
Item
Unit Dose
text
C0013227 (UMLS CUI [1,1])
C0023570 (UMLS CUI [1,2])
C0023570 (UMLS CUI [1,3])
C0869039 (UMLS CUI [1,4])
Item
Units
text
C1519795 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0023570 (UMLS CUI [1,3])
Units
Code List
Units
CL Item
Tablet (TAB)
CL Item
Microlitre (MCL)
CL Item
Millilitre (ML)
CL Item
Litre (L)
CL Item
Microgram (MCG)
CL Item
Milligram (MG)
CL Item
Gram (G)
Item
Frequency
text
C1519795 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0023570 (UMLS CUI [1,3])
Units
Code List
Frequency
CL Item
1x Daily (OD)
CL Item
2x Daily (BID)
CL Item
3x Daily (TID)
CL Item
4x Daily (QID)
CL Item
As required (PRN)
Item
Route
text
C0013153 (UMLS CUI [1,1])
C0023570 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
Route
Code List
Route
CL Item
Intramuscular (IM)
CL Item
Inhalation (IH)
CL Item
Intravenous (IV)
CL Item
Nasal (NS)
CL Item
Topical (TP)
CL Item
Oral (PO)
CL Item
Vaginal (VG)
Reason for Medication
Item
Reason for Medication
text
C0392360 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0023570 (UMLS CUI [1,3])
Start Date
Item
Start Date
date
C0013227 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
C0023570 (UMLS CUI [1,3])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C0023570 (UMLS CUI [1,2])
Ongoing Medication?
Item
Ongoing Medication?
boolean
C0549178 (UMLS CUI [1,1])
C0023570 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial